Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The filing adds to its ever-growing health tech capabilities — and its growing mountain of data to keep safe.
The automakers recent patent for in-vehicle data tracking and analysis adds to the future of connected vehicles.
Both money and time spent on executive corporate jets are still climbing well past pre-pandemic highs, according to the Wall Street Journal.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Boeing is kicking off an image rehabilitation tour after becoming known as the plane-maker whose planes may fall apart mid-air.
Intel could target clients and investors that are interested in socially responsible AI training with it’s recent patent.
Production workers will get a wage increase that curiously follows a strong year for the autoworkers’ union.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Amazon has announced hundreds of layoffs across its Prime Video, TV and film studios, and Twitch businesses.
Overseas sales of China-made cars hit a record high in 2023, likely outpacing Japan to make China the world’s top exporter.
The Federal Aviation Administration is temporarily grounding over 170 of Boeing’s 737 Max 9 aircraft after a scary incident.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.